Member of the Board of Directors since 2021, Member of the Compensation and of the Nominating Committees, US national

Career
Ph.D. in Microbiology from the University of Pittsburgh and B.Sc. from Juniata College; Director Scientific Licensing SmithKline Beecham and Research Scientist at SmithKline Beecham Pharmaceuticals, Vice President S.R. One (Enterprise Fund GlaxoSmithKline, 1999 to 2003), General Partner Venture Fund EuclidSR Partners (2003 to 2008), Vice President Pfizer Ventures (2008 to 2019).

Directorships
Chairwoman of the Board of Directors Gritstone bio and Mironid Ltd since 2019. Member of the Board of Directors Myeloid Therapeutics since 2021, Novartis Venture Fund since 2020, CytomX Therapeutics since 2019 and NextCure since 2016. Member of the Product Development Review Council CPRIT (Cancer Prevention and Research Institute of Texas) since 2022 and Trustee Juniata College since 2014.